Latest Bristol Stories
PARIS, March 1, 2011 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb (NYSE:BMY) announced today that BARACLUDE(R) (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients with evidence of decompensated liver disease. BARACLUDE(r) was already approved in Europe in June 2006 for use in adult patients with CHB with compensated liver disease and evidence of active viral replication, persistently elevated serum alanine...
Chuck Ramsburg will represent MetaSource in booth #4787 at the HIMSS Annual Conference and Exhibition at the Orange County Convention Center in Orlando, Florida on February 20-24, 2011. Bristol, Pennsylvania (Vocus/PRWEB) February 21, 2011 MetaSource, LLC, an industry leader in business process outsourcing (BPO) of back office and content management solutions, will demonstrate their Medical Banking Solution offered to hospitals/providers, and their financial partners.
BRISTOL, Pa. Feb.
BRISTOL, England, January 31, 2011 /PRNewswire/ -- - New UK and European Distributor Announced for Facilis Terrablock - Leading Storage and Post Production Software in use by 1600 Plus Organisations Including Fox TV - Free Installation Offer With Orders Placed at BVE Earls Court 15-17 February Facilis Technology, makers of the Terrablock shared storage and post production system, has today announced major changes to the structure of their business in the UK and Europe,...
Pioneering neurosurgical treatment, a world first in Bristol, which very accurately targets brain networks involved in depression, could help people who suffer with severe and intractable depression.
BRISTOL, Conn. and REDMOND, Wash., Jan.
BRISTOL, Pa., Jan. 7, 2011 /PRNewswire/ -- Aries Electronics, an international manufacturer of standard, programmed and custom interconnection products, now offers machined high-frequency center probe test sockets to accommodate IC devices with a lead pitch of 0.30 mm.
BRISTOL, Tenn. and SAN MATEO, Calif., Dec. 27, 2010 /PRNewswire/ -- King PharmaceuticalsÂ®, Inc. (NYSE: KG) and Pain TherapeuticsÂ®, Inc. (Nasdaq: PTIE) today announced that King has resubmitted a New Drug Application (NDA) for REMOXYÂ® (oxycodone) to the U.S.
BRISTOL, Tenn. and PALATINE, Ill., Dec. 20, 2010 /PRNewswire-FirstCall/ -- King PharmaceuticalsÂ®, Inc. (NYSE: KG) and Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) today announced that King has submitted a New Drug Application (NDA) for ACUROXÂ® (oxycodone HCl) Tablets to the U.S.
Highly regarded industry professional and subject matter expert on EMCâ€™s portfolio of content management products hired to bring additional value to MetaSourceâ€™s reseller network. Bristol, PA (Vocus/PRWEB) December 14, 2010 MetaSource LLC, a leading business process outsourcer (BPO) of back office and content management solutions, announced that Melody Benabou has been hired as the Channel Manager, Western Region. â€œWe are committed to continually bring value to our...
Chalcocite, copper(I) sulfide (Cu2S), is an important copper mineral ore. It is opaque, being colored dark-gray to black with a metallic luster. It has a hardness of 2Â½ - 3. It is a sulfide with an orthorhombic crystal system. Chalcocite is sometimes found as a primary vein mineral in hydrothermal veins. However, most chalcocite occurs in the supergene enriched environment below the oxidation zone of copper deposits as a result of the leaching of copper from the oxidized minerals. It is...
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.